$15.70
4.32% today
Nasdaq, Aug 12, 09:18 pm CET
ISIN
US35803L1089
Symbol
KRRO

Frequency Therapeutics Inc Stock price

$15.05
+2.34 18.41% 1M
-15.29 50.40% 6M
-23.02 60.47% YTD
-20.92 58.16% 1Y
-82.95 84.64% 3Y
-1,163.95 98.72% 5Y
-669.95 97.80% 10Y
-669.95 97.80% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.95 5.94%
ISIN
US35803L1089
Symbol
KRRO
Industry

Key metrics

Basic
Market capitalization
$141.3m
Enterprise Value
$26.4m
Net debt
positive
Cash
$115.0m
Shares outstanding
9.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
29.3 | 37.7
EV/Sales
5.5 | 7.0
EV/FCF
negative
P/B
1.0
Financial Health
Equity Ratio
70.9%
Return on Equity
-52.1%
ROCE
-50.4%
ROIC
-119.8%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$4.8m | $3.7m
EBITDA
$-91.4m | -
EBIT
$-95.5m | $-101.4m
Net Income
$-87.4m | $-91.4m
Free Cash Flow
$-75.1m
Growth (TTM | estimate)
Revenue
- | 65.2%
EBITDA
-11.3% | -
EBIT
-11.7% | -10.3%
Net Income
-7.7% | -9.4%
Free Cash Flow
15.1%
Margin (TTM | estimate)
Gross
-
EBITDA
-1,896.1% | -
EBIT
-1,980.4%
Net
-1,813.1% | -2,438.7%
Free Cash Flow
-1,556.6%
More
EPS
$-9.3
FCF per Share
$-8.0
Short interest
15.5%
Employees
104
Rev per Employee
$20.0k
Show more

Is Frequency Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Frequency Therapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Frequency Therapeutics Inc forecast:

15x Buy
94%
1x Hold
6%

Analyst Opinions

16 Analysts have issued a Frequency Therapeutics Inc forecast:

Buy
94%
Hold
6%

Financial data from Frequency Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4.82 4.82
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 31 31
17% 17%
633%
- Research and Development Expense 70 70
17% 17%
1,448%
-91 -91
11% 11%
-1,896%
- Depreciation and Amortization 4.06 4.06
21% 21%
84%
EBIT (Operating Income) EBIT -95 -95
12% 12%
-1,981%
Net Profit -87 -87
8% 8%
-1,813%

In millions USD.

Don't miss a Thing! We will send you all news about Frequency Therapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Frequency Therapeutics Inc Stock News

Neutral
GlobeNewsWire
about 9 hours ago
— Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 on track for the second half of 2025 — Completed dosing of over 80% of planned REWRITE healthy volunteers across multiple single ascending dose (SAD)  cohorts with no treatment emergent serious adverse events (SAEs) or dose limiting toxicities observed — European Medicines Agency (EMA) granted Orphan Drug Designation to KRRO-1...
Neutral
GlobeNewsWire
22 days ago
CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, announced today that it has been granted orphan drug designation by the European Medicines Agency (EMA) Committee, who adopted a positive opi...
Neutral
GlobeNewsWire
3 months ago
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor conferences: 2025 RBC Capital Markets Global Healthcare Conference Ram Aiyar, Ph.D.
More Frequency Therapeutics Inc News

Company Profile

Frequency Therapeutics, Inc. engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA.

Head office United States
CEO Ram Aiyar
Employees 104
Founded 2018
Website www.korrobio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today